Triple-valve replacement in repaired tetralogy of fallot patients with mirror-image dextrocardia: a case report Authors: Rui Lv, Deming Liu, Xiaona Lin, Juncheng Jiang, Chuanguo Xu, Hao Zhang, Bin Qiao Published: 2026 ABSTRACT AbstractBackgroundThe co-occurrence of mirror-image dextrocardia and tetralogy of Fallot (TOF) is a rare congenital condition. Reoperative multivalve surgery in such patients, especially after repaired TOF, presents exceptional challenges due to the mirrored cardiac anatomy and altered surgical field. This case highlights the surgical strategy for concomitant tricuspid, mitral, and pulmonary valve replacement in this unique setting.Case presentationA 14-year-old male patient with a history of corrected TOF and mirror-image dextrocardia presented with progressive heart failure due to severe regurgitation of the tricuspid, mitral, and pulmonary valves. Preoperative imaging confirmed the complex anatomy, with the atria positioned posteriorly, rendering the atrioventricular valve orifices near-vertical during surgery. The patient successfully underwent triple valve replacement under cardiopulmonary bypass. Key technical adaptations were made to select the valve model and position. The postoperative course was uneventful, with significant symptomatic and echocardiographic improvement at discharge and during the two-month and six-month follow-up.ConclusionThis case demonstrates that concomitant triple valve replacement is feasible in patients with mirror-image dextrocardia and a history of TOF repair, despite the profound technical challenges posed by the anatomical distortions. Success hinges on meticulous preoperative planning using advanced imaging and the development of an individualized surgical approach. This report provides a valuable reference for managing such complex, high-risk reoperations in the setting of congenital situs inversus.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13019-026-04146-1.Keywords: Mirror-image dextrocardia, Repaired tetralogy of fallot, Valve replacement, Congenital heart disease, Case report Background Mirror-image dextrocardia is an uncommon condition characterized by a right-sided cardiac apex and a mirror-reversed arrangement of the heart chambers and great vessels [1]. Tetralogy of Fallot (TOF) is a common cyanotic congenital heart defect, and long-term survival after initial corrective surgery is excellent. However, a significant number of survivors require reintervention for late sequelae, particularly pulmonary valve regurgitation, which can lead to right ventricular dysfunction and secondary tricuspid regurgitation [2, 3]. Left-sided valve pathology, such as mitral regurgitation, is less common in this population [4, 5]. Managing patients who require reoperation after initial TOF repair is already complex due to adhesions and altered anatomy. When this scenario is superimposed on the mirror-image anatomy of dextrocardia, the conventional surgical orientations and sightlines are completely altered, making exposure and prosthetic valve implantation more complex. Literature on re-operative multivalve surgery in adults with both mirror-image dextrocardia and repaired TOF is exceedingly scarce [6]. Standard surgical textbooks and guidelines offer limited guidance for these “anatomically extreme” cases. Therefore, reporting such a case is of paramount importance. This report aims to detail the surgical management and perioperative considerations for a patient with this unique combination of conditions, focusing on the technical adaptations required to successfully perform triple valve replacement, particularly the selection of valve models and positions involved. The insights gained can inform surgical strategies for other complex congenital heart disease reoperations involving unusual thoracic situs. Case presentation A 14-year-old boy with mirror-image dextrocardia and repaired tetralogy of Fallot (rToF), who had undergone staged surgical correction (Blalock-Taussig shunt in 2012, complete repair in 2014), was admitted in August 2025 for right heart failure with NYHA Class III symptoms. In August 2025, the patient was admitted due to right heart dysfunction. Electrocardiography revealed complete right bundle branch block. Doppler echocardiography demonstrated severe mitral, tricuspid, and pulmonary valve regurgitation (Fig. 1, A-C). Further imaging, including X-ray, right heart catheterization with angiography, and cardiac computed tomographic angiography (CTA) (Fig. 1, D-G), showed a cardiothoracic ratio of 0.52 and significant dilation of the right ventricular outflow tract. Key echocardiography, CTA and Cardiac magnetic resonance (CMR) parameters, including ventricular volumes, valve annular diameters, and regurgitation fractions, are presented in Table 1. Final Diagnosis: rToF, mirror-image dextrocardia, mitral and tricuspid valve insufficiency, severe pulmonary valve regurgitation. Preoperatively, dopamine was infused at 3 µg/kg/min for 5 days (hospital day 9–13) to optimize cardiac function and hemodynamics, with surgery performed the day after withdrawal. Oral diuretics were administered for 14 days before surgery. Preoperative imaging evaluation. (A–C) Doppler echocardiography showing mitral, tricuspid and pulmonary regurgitation; (D) Posteroanterior chest radiograph; (E) Posteroanterior angiographic image; (F) Lateral angiographic image; (G) Three-dimensional reconstruction of cardiac computed tomography angiography (CTA). White “L”: the left-sided structures; Red asterisk: left ventricle; Blue asterisk: right ventricle Table 1Preoperative evaluation and key measurements from echocardiography, CTA, and CMR. PA: pulmonary artery; RV: right ventricular; EF: ejection fractionParametersValuePreoperative Doppler echocardiography (mm)atriumright56 × 48left52 × 39ventricular left-right diameterright71left56PAmain23left11right14preoperative Cardiac CTA (cm)mid-segmentmain PA1.9 × 1.8left PA1.6 × 1.2right PA1.3 × 1.1Cardiac Magnetic Resonance Parametersend-diastolicRV diameter6.6 cmvolume164 mlvolume index111.7 ml/m²end-systolicvolume99 mlvolume index67.3 ml/m²right ventricular EF39.6%mitral valve annular diameterssystole39.1 mmdiastole43.1 mmtricuspid valve annular diameterssystole33.6 mmdiastole47.58 mmtricuspid regurgitation fraction55.1%pulmonary valve annular diametersystole22.7 mmdiastole22.6 mmpulmonary regurgitation fraction56.0% Preoperative evaluation and key measurements from echocardiography, CTA, and CMR. PA: pulmonary artery; RV: right ventricular; EF: ejection fraction On August 27, 2025, the patient underwent triple mechanical valve replacement (mitral, tricuspid, and pulmonary), RV reconstruction, and main pulmonary artery (PA) augmentation under general anesthesia with cardiopulmonary bypass (CPB). A median sternotomy was performed. After routine CPB establishment, the aorta was cross‑clamped, and cardioplegic solution (HTK solution) was infused to induce cardiac arrest. The mitral valve was exposed through a right atriotomy and an interatrial septal incision. Because of cardiac malposition, the mitral valve was displaced superiorly with a small annulus. The posterior leaflet was adherent to the left ventricular wall, the chordae tendineae were thin, and the anterior leaflet was prolapsed and dysplastic. The mitral valve leaflets and chordae were excised, and the mitral annulus accepted a #25 sizer. A #25 bileaflet mechanical valve (Medtronic ATS open PIVOT) was implanted using interrupted 2‑0 pledgeted sutures. The tricuspid valve was exposed through the right atriotomy. Due to right ventricular dilatation with excessively elongated and thin chordae, two clefts in the leaflets, and insufficient septal leaflet area with structural damage from the previous ventricular septal defect repair, the tricuspid valve was excised. A #29 bileaflet mechanical valve (Medtronic ATS open PIVOT) was implanted using interrupted 3‑0 braided polyester sutures without pledgets to minimize foreign material for thrombus formation in the right heart system. The calcified right ventricular outflow tract (RVOT) and the previously placed pulmonary artery augmentation patch were resected. The RVOT was sized with a 1.8 cm probe, and a portion of the anterior right ventricular wall was excised. For pulmonary valve implantation, interrupted 2‑0 pledgeted sutures were placed, with the suture line positioned 1–2 cm below the native pulmonary annulus. The inferior sutures were passed through the supraventricular crest, and the lateral sutures were placed along the right ventricular free wall. The main pulmonary artery was augmented with a bovine pericardial patch. On the anterior wall, a “sandwich” suture technique was used to incorporate the bovine pericardial patch, the prosthetic sewing ring, and the right ventricular anterior wall. All pledgets and knots were placed on the right ventricular side. An #19 ON‑X mechanical valve (CryoLife, Aortic Heart Valve) was implanted. The right ventricular anterior wall incision was closed directly with an edge‑to‑edge suture. The atrial septal incision was closed with a running 4‑0 Prolene suture. A left atrial pressure monitoring line was placed, and the right atriotomy was closed. The aortic cross‑clamp was removed, and the heart resumed beating spontaneously. Cardiopulmonary bypass time was 189 min, and aortic cross‑clamp time was 104 min. Weaning from CPB was uneventful. Intraoperative transesophageal echocardiography revealed well- positioned prosthetic valves with no significant regurgitation, no paravalvular leak, and a left ventricular ejection fraction of 0.50. After hemostasis, the chest was closed in layers, and the patient was transferred to the ICU in stable condition. The patient was weaned from mechanical ventilation after 18 h. Hemodynamic support in the ICU included inotropes (dopamine, milrinone), vasopressors (norepinephrine), and vasodilators (sodium nitroprusside, nitroglycerin), with amiodarone for arrhythmia prophylaxis over a 5-day ICU stay. The subsequent recovery was uneventful, and the patient was discharged on postoperative day 15 in stable condition (NYHA Class II) (Fig. 2, A-B). Postoperative and follow-up imaging. (A) Posteroanterior chest radiograph at 10 days after surgery; (B) Posteroanterior angiographic image at 2 months; (C) Posteroanterior chest radiograph at 2 months; (D) Posteroanterior chest radiograph at 6 months; (E–G) Spectral tracings of the mitral, tricuspid, and pulmonary valves at 6 months. White “L”: the left-sided structures. Colored arrows indicate the valve positions. Yellow arrows: mitral valve; Green arrows: tricuspid valve; White arrows: pulmonary valve At the two-month and six-month follow-up, a chest X-ray revealed a reduced cardiothoracic ratio (Fig. 2C-D, 0.47 and 0.46, from 0.52 preoperatively). Echocardiography demonstrated well-functioning prosthetic valves with maximum flow velocities of 1.9 m/s (pulmonary), 1.6 m/s (mitral), and 1.0 m/s (tricuspid), along with an improved right ventricular diameter (47 mm). Spectral tracings of the mitral, tricuspid, and pulmonary valves at 6 months follow-up are shown in Fig. 2E-G. Discussion Impact of resecting the right ventricular outflow tract patch on right ventricular remodeling and function Resection of the severely calcified and noncompliant previous RVOT patch was critical to reverse its adverse effects on right ventricular geometry and contractile synchrony [6]. The RVOT edges coapted well enough to allow for primary closure without a patch. Given the patient’s preexisting pulmonary hypoplasia (main PA diameter: 18.5 mm), the anterior wall was augmented to relieve tension. This combined approach of patch resection and selective pulmonary arterioplasty established a tailored hemodynamic environment conducive to right ventricular recovery. Selection of the size and position of the prosthetic valve For this patient, with a body surface area of 1.47 m², the following valve prostheses were selected: a #25 mitral valve with an EOA of 2.1 cm² and an EOA index (EOAI) of 1.40 cm²/m²; a #29 tricuspid valve with an EOA of 3.1 cm² and an EOAI of 2.07 cm²/m²; and a #19 pulmonary valve with an EOA of approximately 1.5 ± 0.2 cm² and an EOAI of 1.0 cm²/m². This sizing strategy aimed to minimize adverse effects on right ventricular function and PA elasticity. The choice of valve implantation site directly influences prosthesis sizing. The effective orifice areas (EOA) and EOAI were obtained from the respective product technical manuals (Medtronic ATS Open Pivot Valve Technical Manual, Medtronic, Inc., Minneapolis, MN, USA; ON-X Valve Product Information Manual, CryoLife, Inc., Kennesaw, GA, USA). Pulmonary valve Prosthetic valve selection and positioning must balance optimal hemodynamics with anatomical constraints to meet long-term physiological demands. While annular diameter and effective orifice area (EOA) guide sizing [7, 8], the morphology of the right ventricular outflow tract is particularly critical in pulmonary valve selection. Although a larger EOA reduces the transvalvular gradient and cardiac workload, oversized prostheses should be avoided. This patient presented with biventricular systolic and diastolic dysfunction and poor volume tolerance. We therefore opted for relatively smaller valves to effectively control regurgitation without overloading the ventricles. For the mechanical valves used, long-term anticoagulation is required; however, the associated higher flow velocities may increase blood washout across the prosthesis, potentially reducing thrombotic risk. The choice of valve implantation site directly influences prosthesis sizing. Mechanical valves require stable structural support, typically provided by the native annulus [6, 9]. In this case, we therefore utilized the well-developed right ventricular infundibulum which was free of obstruction and provided adequate support as an alternative site, enabling the implantation of a relatively larger valve with a greater effective orifice area. Trabeculations at the base of the conus arteriosus were resected to minimize the risk of iatrogenic RVOT obstruction [9]. A #19 mechanical valve was ultimately implanted in the smooth infundibular region just proximal to the annulus, combined with supraannular PA augmentation to better restore physiological right heart hemodynamics. All sutures were tied on the right ventricular side to avoid any rough surface inside the pulmonary artery lumen, thereby reducing the risk of thrombosis. During right ventricular remodeling, the thinned anterior wall was trimmed and reshaped intraoperatively due to extreme right ventricular dilatation, creating a more favorable geometric environment for the newly implanted valve. Postoperative assessment confirmed significant improvement in right ventricular morphology and function, although long-term follow-up is warranted. Tricuspid valve Long-standing cardiac dysfunction had caused severe right ventricular dilatation with excessively elongated and thin chordae, two clefts in the leaflets, and insufficient septal leaflet area with structural damage from the previous ventricular septal defect repair. These findings made durable results of valvuloplasty unlikely. Therefore, tricuspid valve replacement was performed. The thrombotic risk of a mechanical valve in the tricuspid position is relatively high, but it can be rigorously managed through a standardized and individualized anticoagulation regimen to reduce the risk to a controllable range. Compared with the risks of valve repair failure or accelerated bioprosthetic valve degeneration, the benefits of a mechanical valve far outweigh the risks. Therefore, the mechanical valve was implanted without pledgets to minimize the foreign material basis for thrombus formation in the right heart system. Mitral valve The patient had mirror-image dextrocardia with congenital variations in the spatial position and morphological structure of the left ventricle and the mitral valve annulus. Preoperative imaging and intraoperative findings both indicated valve dysplasia, a small annulus, short posterior leaflet chordae that attached directly to the left ventricular wall, which restricted leaflet motion, and anterior leaflet prolapse. These structural abnormalities made repair difficult, leading to the choice of valve replacement. Preoperative echocardiography confirmed severe mitral regurgitation, chordal rupture and prolapse, and coaptation failure due to curling prolapse (see supplement material). Intraoperative measurement showed that the annulus could only accommodate a #25 mechanical valve. Based on the patient’s body surface area, the orifice area of the #25 valve is sufficient to meet hemodynamic demands, and the mechanical valve offers excellent durability. Anticoagulation and follow‑up strategy Warfarin was started 24 h after surgery at an initial dose of 3 mg, with daily INR monitoring targeting a range of 2.5–3.0. Warfarin pharmacogenetic testing was also performed to guide dosing. Within the first month after discharge, INR was checked every 10 days. As INR stabilized, the interval was gradually prolonged. During the first three postoperative months, INR was monitored monthly. In long‑term follow‑up, the monitoring frequency is adjusted based on INR stability. No antiplatelet agents were routinely added. Although the thrombotic risk of mechanical valves in the tricuspid and pulmonary positions is higher than in the left heart, experience indicates shows that maintaining INR at 2.5-3.0 effectively prevents thrombosis without the need for routine antiplatelet drugs. The patient will undergo long‑term follow‑up every 12 months, during which assessments are made for any symptoms of embolism (dyspnea, syncope, limb ischemia, etc.) and bleeding complications (mucocutaneous bleeding, hematuria, gastrointestinal bleeding, etc.). No thrombotic or bleeding events occurred in this case postoperatively or during the follow-up period. Conclusion This case demonstrates that successful reoperation for multivalvular disease in patients with mirror-image dextrocardia and rToF depends critically on tailored surgical strategies, including RVOT reconstruction and precise valve management. It serves as an instructive reference for the surgical approach to such complex scenarios. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Material 7 Supplementary Material 8 Acknowledgements The authors thank the patients who participated in this study. Abbreviations Cardiac magnetic resonance Cardiopulmonary bypass Computed tomographic angiography Ejection fraction Effective orifice area Effective orifice area index Intensive care unit New York heart association Pulmonary artery Repaired tetralogy of fallot Right ventricular Right ventricular end-diastolic volume index Right ventricular outflow tract Author contributions Rui Lv, Deming Liu, Juncheng Jiang: writing, original draft. Xiaona Lin, Deming Liu, Chuanguo Xu, Hao Zhang, Bin Qiao: surgical procedure. Rui Lv, Bin Qiao: provision of study materials, conception and design. All authors read and approved the final manuscript. Funding The Natural Science Foundation of Shandong Province (No. ZR2024QA110). Shandong Province Medical Health Science and Technology Project (No. 202425020256, and 202403010254). Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The Ethics Committee of Shandong Second Provincial General Hospital affiliated with Shandong University (approval code: 2025-001-01). We obtained written informed consent from the parents of the participant. Consent for publication The guardian gave consent for publication. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rui Lv and Deming Liu contributed equally to this work. Contributor Information Rui Lv, Email: lvrui1995seu@163.com. Bin Qiao, Email: cijnmd@126.com. References Associated Data Supplementary Materials Supplementary Material 1 Supplementary Material 2 Supplementary Material 3 Supplementary Material 4 Supplementary Material 5 Supplementary Material 6 Supplementary Material 7 Supplementary Material 8 Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.